SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-003598
Filing Date
2024-05-17
Accepted
2024-05-17 09:00:13
Documents
18
Period of Report
2024-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_8k.htm   iXBRL 8-K 31475
2 OPINION OF HOGAN LOVELLS US LLP phio_ex0501.htm EX-5.1 9385
3 PURCHASE AGREEMENT, DATED MAY 16, 2024, BY AND BETWEEN PHIO PHARMACEUTICALS CORP phio_ex1001.htm EX-10.1 165876
4 PRESS RELEASE phio_ex9901.htm EX-99.1 11337
5 GRAPHIC hoganlovellslogo.jpg GRAPHIC 8406
9 GRAPHIC image_001.jpg GRAPHIC 2297
  Complete submission text file 0001683168-24-003598.txt   449468

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE phio-20240516.xsd EX-101.SCH 3021
7 XBRL LABEL FILE phio-20240516_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE phio-20240516_pre.xml EX-101.PRE 22363
21 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3700
Mailing Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752
Business Address 11 APEX DRIVE, SUITE 300A PMB 2006 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 24957855
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)